Mode
Text Size
Log in / Sign up

Genetic liability for cannabis use is causally linked to increased risk of esophageal and lung cancersGenetic data reveals link between cannabis use and certain cancers

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that genetic liability for cannabis use is causally linked to higher risk for esophageal and lung cancers.

This meta-analysis utilizes two-sample Mendelian Randomization to investigate the causal relationship between genetic liability to cannabis use and site-specific cancers, including esophageal, lung, and pancreatic cancers. The study adjusted for cigarette smoking to isolate the effects of cannabis-related genetic markers.

The analysis identified a significant causal association between cannabis use and increased risk for both esophageal cancer (OR 1.74; 95% CI [1.29-2.15], p=0.013) and lung cancer (OR 1.35; 95% CI [1.13-1.58], p=0.009). Conversely, the study reported a protective effect for pancreatic cancer (OR 0.77; 95% CI [0.57-0.91], p=0.032) in relation to cannabis use genetic liability.

The findings are derived from Mendelian Randomization, which uses genetic variants as instrumental variables to infer causality. While the results suggest specific risks for esophageal and lung cancers, the clinical application of these findings is limited by the nature of genetic proxies and the lack of reported limitations or safety data in the source.

How this fits prior evidence

This finding addresses a gap regarding the causal impact of cannabis use on cancer risk. It provides new evidence specifically regarding esophageal and lung cancer risks associated with cannabis, which complements existing knowledge on lung cancer management and outcomes mentioned in prior coverage.

When we look at how our habits affect our health, it can be hard to tell if a behavior directly causes a disease or if other factors are involved. To get a clearer picture, researchers used a method called Mendelian Randomization. This approach uses a person's genetic makeup as a proxy for their behavior to see if there is a direct causal link.

The study looked at people of European ancestry and found specific links between the genetic tendency to use cannabis and three types of cancer. The results showed that this genetic liability was associated with an increased risk of both esophageal cancer and lung cancer, even when accounting for cigarette smoking.

Interestingly, the data also showed a protective effect regarding pancreatic cancer. While the study provides important clues about how genetics and substance use interact with cancer risks, it is still early research based on genetic markers rather than direct clinical trials.

What this means for you:
Genetic evidence suggests cannabis use may increase lung and esophageal cancer risk while showing a protective link to pancreatic cancer.

Common questions

Does this study mean cannabis causes cancer?

The study used Mendelian Randomization, which uses genetic markers to look for a causal link. It found that the genetic tendency toward cannabis use was associated with an increased risk of lung and esophageal cancer, but it showed a protective effect for pancreatic cancer.

What specific cancers were linked to cannabis use?

The research specifically looked at three types: esophageal cancer, lung cancer, and pancreatic cancer. The results showed increased risks for the first two, while the third showed a lower risk associated with the genetic tendency toward cannabis use.

Was cigarette smoking taken into account?

Yes, the researchers adjusted their findings to account for cigarette smoking when looking at the link between cannabis use and esophageal and lung cancers. This helps clarify the specific impact of cannabis-related genetics on those risks.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
Background: The prevalence of cannabis use is increasing at an alarming rate owing to its legalization and decriminalization in some countries. Epidemiological evidence on the association between cannabis use and cancer is inconsistent and conflicting. Herein, we performed two-sample Mendelian randomization (MR) to investigate whether cannabis use is causally associated with site-specific cancers in individuals of European ancestry. Methods: We identified 22 independent genetic variants strongly associated with cannabis use (p-value < 5 x 10-8) in a large meta-analysis of genome-wide association studies of individuals of European ancestry. Genome-wide association summary-level data on site-specific cancers were obtained from individuals of European ancestry in FinnGen, Finland. MR analyses were performed using the inverse-variance weighted (IVW) and multivariable method. Sensitivity analyses were performed using the simple median, weighted median, MR-Egger, and MR pleiotropy residual sum and outlier methods. Results: Our multivariable IVW analyses adjusted for cigarette smoking found that genetic liability to cannabis use was causally associated with esophageal cancer (odds ratio [OR] =1.74, 95% confidence interval [CI] =1.29-2.15, p-value =0.013) and lung cancer (OR=1.35, 95% CI = 1.13-1.58, p-value =0.009). However, genetic liability to cannabis use exerted a protective effect against pancreatic cancer (OR=0.77, 95% CI =0.57-0.91, pvalue=0.032) in individuals of European ancestry in the FinnGen. Our sensitivity analyses found no evidence of horizontal pleiotropy between cannabis use and site-specific cancers. Conclusion: We found that genetic liability to cannabis use was associated with esophageal, lung, and pancreatic cancers in individuals of European ancestry.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.